T–cell–based immunotherapy for osteosarcoma: challenges and opportunities
AbstractEven though combining surgery with chemotherapy has significantly improved the prognosis of osteosarcoma patients, advanced, metastatic or recurrent osteosarcomas are often nonresponsive to chemotherapy, making development of novel efficient therapeutic methods an urgent need. Adoptive immun...
| Váldodahkkit: | , , , |
|---|---|
| Materiálatiipa: | Artihkal |
| Giella: | English |
| Almmustuhtton: |
Frontiers Media S.A.
2016-09-01
|
| Ráidu: | Frontiers in Immunology |
| Fáttát: | |
| Liŋkkat: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00353/full |